These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36372720)

  • 21. De novo aortic regurgitation after continuous-flow left ventricular assist device implantation.
    Patil NP; Sabashnikov A; Mohite PN; Garcia D; Weymann A; Zych B; Bowles CT; Hards R; Hedger M; Popov AF; De Robertis F; Moza A; Bahrami T; Amrani M; Rahman-Haley S; Banner NR; Simon AR
    Ann Thorac Surg; 2014 Sep; 98(3):850-7. PubMed ID: 25069685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feasibility and efficacy of the 2.5 L and 3.8 L impella percutaneous left ventricular support device during high-risk, percutaneous coronary intervention in patients with severe aortic stenosis.
    Spiro J; Venugopal V; Raja Y; Ludman PF; Townend JN; Doshi SN
    Catheter Cardiovasc Interv; 2015 May; 85(6):981-9. PubMed ID: 24408882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aortic Valve Insufficiency as a Late Complication After Impella Device Implantation.
    Olsthoorn JR; Goossens EAC; Lam K; Tonino PAL; van Dantzig JM
    JACC Cardiovasc Interv; 2022 Apr; 15(8):e91-e93. PubMed ID: 35367172
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy and durability of central oversewing for treatment of aortic insufficiency in patients with continuous-flow left ventricular assist devices.
    Schechter MA; Joseph JT; Krishnamoorthy A; Finet JE; Ganapathi AM; Lodge AJ; Milano CA; Patel CB
    J Heart Lung Transplant; 2014 Sep; 33(9):937-42. PubMed ID: 24997496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-Term Recovery of Reduced Left Ventricular Ejection Fraction after Aortic Valve Replacement in Patients with Bicuspid Aortic Valve Disease.
    Disha K; Espinoza A; Rouman M; Secknus MA; Kuntze T; Girdauskas E
    Thorac Cardiovasc Surg; 2016 Aug; 64(5):418-26. PubMed ID: 26251215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural history and clinical effect of aortic valve regurgitation after left ventricular assist device implantation.
    Rajagopal K; Daneshmand MA; Patel CB; Ganapathi AM; Schechter MA; Rogers JG; Milano CA
    J Thorac Cardiovasc Surg; 2013 May; 145(5):1373-9. PubMed ID: 23312101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous retrograde left ventricular assist support for interventions in patients with aortic stenosis and left ventricular dysfunction.
    Martinez CA; Singh V; Londoño JC; Cohen MG; Alfonso CE; O'Neill WW; Heldman AW
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1201-9. PubMed ID: 22511541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Impella Recover microaxial left ventricular assist device reduces mortality for postcardiotomy failure: a three-center experience.
    Siegenthaler MP; Brehm K; Strecker T; Hanke T; Nötzold A; Olschewski M; Weyand M; Sievers H; Beyersdorf F
    J Thorac Cardiovasc Surg; 2004 Mar; 127(3):812-22. PubMed ID: 15001911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of progressive aortic regurgitation on outcomes after left ventricular assist device implantation.
    Gasparovic H; Jakus N; Brugts JJ; Pouleur AC; Timmermans P; Rubiś P; Gaizauskas E; Van Craenenbroeck EM; Barge-Caballero E; Grundmann S; Paolillo S; D'Amario D; Braun OÖ; Meyns B; Droogne W; Wierzbicki K; Holcman K; Planinc I; Lovric D; Flammer AJ; Petricevic M; Biocina B; Lund LH; Milicic D; Ruschitzka F; Cikes M
    Heart Vessels; 2022 Dec; 37(12):1985-1994. PubMed ID: 35737119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maintenance of valvular integrity with Impella left heart support: Results from the multicenter PROTECT II randomized study.
    Goldstein JA; Dixon SR; Douglas PS; Ohman EM; Moses J; Popma JJ; O'Neill WW
    Catheter Cardiovasc Interv; 2018 Oct; 92(4):813-817. PubMed ID: 28988424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transfemoral aortic valve replacement for severe aortic valve regurgitation in a patient with a pulsatile-flow biventricular assist device.
    Gomes B; Bekeredjian R; Leuschner F; Ehlermann P; Schmack B; Ruhparwar A; Raake PW; Katus HA; Kreusser MM
    ESC Heart Fail; 2019 Feb; 6(1):217-221. PubMed ID: 30479049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiographic assessment of aortic regurgitation by video-densitometry in the setting of TAVI: Echocardiographic and clinical correlates.
    Abdelghani M; Tateishi H; Miyazaki Y; Cavalcante R; Soliman OII; Tijssen JG; de Winter RJ; Baan J; Onuma Y; Campos CM; Leite RS; Mangione JA; Abizaid A; Lemos PA; de Brito FS; Serruys PW
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):650-659. PubMed ID: 28109043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of aortic valve opening in patients with aortic insufficiency after left ventricular assist device implantation.
    da Rocha E Silva JG; Meyer AL; Eifert S; Garbade J; Mohr FW; Strueber M
    Eur J Cardiothorac Surg; 2016 Mar; 49(3):784-7. PubMed ID: 26084757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of the Development of Aortic Regurgitation After Impella Left Ventricular Assist Device Support.
    Imamura T
    J Cardiothorac Vasc Anesth; 2020 Sep; 34(9):2550-2551. PubMed ID: 32475779
    [No Abstract]   [Full Text] [Related]  

  • 35. Rescue TAVI for Aortic Regurgitation after Left Ventricular Assist Device Implantation Following Preoperative Impella® Support.
    M Herrmann FE; Wellmann P; von Dossow V; Massberg S; Hagl C; Schramm R; Pichlmaier M
    J Heart Valve Dis; 2017 Sep; 26(5):603-605. PubMed ID: 29762934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous transcatheter aortic valve closure successfully treats left ventricular assist device-associated aortic insufficiency and improves cardiac hemodynamics.
    Parikh KS; Mehrotra AK; Russo MJ; Lang RM; Anderson A; Jeevanandam V; Freed BH; Paul JD; Karol J; Nathan S; Shah AP
    JACC Cardiovasc Interv; 2013 Jan; 6(1):84-9. PubMed ID: 23347865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiogenic Shock Complicating Transcatheter Aortic Valve Replacement Due to Severe Para-Valvular Regurgitation.
    Alraies MC; Soud M; Pacha HM; Waksman R; Ben-Dor I
    Cardiovasc Revasc Med; 2018; 19(3 Pt B):393-395. PubMed ID: 29146552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of pump rotation speed on hemodynamics and myocardial oxygen metabolism in left ventricular assist device support with aortic valve regurgitation.
    Iizuka K; Nishinaka T; Takewa Y; Yamazaki K; Tatsumi E
    J Artif Organs; 2017 Sep; 20(3):194-199. PubMed ID: 28429120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complete fusion of a percutaneous aortic valve placed after ventricular assist device.
    Derryberry SL; Williams RD; Fredi JL; Ball SK
    Interact Cardiovasc Thorac Surg; 2017 Aug; 25(2):329-330. PubMed ID: 28475802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical impact of aortic regurgitation after transcatheter aortic valve replacement: insights into the degree and acuteness of presentation.
    Jerez-Valero M; Urena M; Webb JG; Tamburino C; Munoz-Garcia AJ; Cheema A; Dager AE; Serra V; Amat-Santos IJ; Barbanti M; Immè S; Alonso Briales JH; Al Lawati H; Benitez LM; Cucalon AM; Garcia del Blanco B; Revilla A; Dumont E; Barbosa Ribeiro H; Nombela-Franco L; Bergeron S; Pibarot P; Rodés-Cabau J
    JACC Cardiovasc Interv; 2014 Sep; 7(9):1022-32. PubMed ID: 25234675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.